Important Update:
AMP GLOBAL 2025 Postponed
AMP Middle East 2025
To Take Place
Join us at AMP Middle East 2025

PROGRAM COMING SOON

REGISTRATION

EXPLORE SPONSORSHIP OPPORTUNITIES

IMPORTANT UPDATE

We regret to inform you that due to unforeseen challenges related to the venue, the AMP Global 2025 Congress in Abu Dhabi has been postponed. However, we are excited to announce that AMP Middle East 2025 will take place on April 12-13, 2025. For more details and to register, please visit AMP Middle East 2025.

We are working diligently to finalize a new venue and dates for the AMP Global event for a future year and will share these details as soon as possible. In the meantime, we encourage you to join us for AMP Middle East 2025 and look forward to seeing you there! For more information on the Association for Molecular Pathology (AMP) or educational resources, please visit the AMP Website.

Stay tuned for more information and thank you for your understanding.

STAY TUNED

We are working diligently to finalize a new venue and dates for the AMP Global event for a future year and will share these details as soon as possible.

GET ACCESS TO OUR LATEST NEWS

Stay connected with all of the latest updates by signing up to the mailing list.

By clicking on ‘Subscribe’, you agree to receive the newsletter with information on AMP Global 2025 and to analyze it through individual measurement, storage and evaluation of opening rates and click rates in recipient profiles for the purpose of designing future newsletters according to the interests of our readers. You can revoke your consent at any time for the future as follows. You will find detailed information in our see our privacy statement.

REASONS TO ATTEND AMP GLOBAL

Access early results


of major molecular diagnostic studies, implementation strategies, quality improvements in patient care, and more.

Stay up-to-date


on advancements in technology by attending industry symposia and exploring exhibits

Connect and network


with fellow molecular pathology professionals in our collegial congress setting.

Find answers


to your questions and discover new paths of scientific inquiry in conversation with molecular experts from around the world

GET TO KNOW THE ASSOCIATION FOR MOLECULAR PATHOLOGY

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics.

AMP’s 2,900+ members include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees.

MORE ABOUT AMP

Federico Monzon

Federico A. Monzon is a molecular pathologist with extensive experience translating novel genomic technologies into clinical molecular tests, including leading studies on prostate and renal cancer genomics and the validation of one of the first FDA-cleared gene expression clinical assays for the diagnosis of tumors of unknown origin while at the University of Pittsburgh and Houston Methodist Hospital. At Invitae and Baylor Genetics laboratories, he pioneered the use of panel testing for hereditary cancers as well as cancer exome sequencing.

Dr. Monzon is a consultant on medical and scientific strategy for companies in the diagnostic space. Currently, he is Chief Medical Officer (CMO) at Delphi Diagnostics, a laboratory focused on providing genomic tools for the management of breast cancer patients. Prior to that, he served as CMP for Castle Diagnostics and served as Medical Director of Oncology and Medical Director for Latin America at Invitae Corporation. Previously, Dr. Monzon served as Director of Pathology at the Cancer Genetics Laboratory at Baylor College of Medicine. He earned his M.D. from the Universidad Nacional Autónoma de México (UNAM) and is board-certified by the American Board of Pathology in anatomic, clinical and molecular genetic pathology. Dr Monzon was the 2017 President of the Association for Molecular Pathology (AMP) and continues to be engaged in AMP and other professional societies to shape the future of clinical genomic medicine.

Soon!